Advertisement

'Devastating' Consequences If Big Pharma Firms Don't Rethink Antibiotics

Sky's Ian King spoke to Jim O'Neill earlier today, who's chaired a report into the funding of a new generation of antibiotics, and he began by explaining why his team reached the conclusions they came to.